- Corporate Officers - Z
- Zaccardelli David
Insider Trading History of Zaccardelli David
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Zaccardelli David since 2015.
This trader's CIK number is 1627642.
At the time of last reporting, Zaccardelli David was the President and CEO of Verona Pharma Plc. (stock ticker symbol VRNA).
Also see all insider trading activities at Verona Pharma Plc.
Note that in the past
ZACCARDELLI DAVID also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at United Therapeutics Corp (UTHR) by Zaccardelli David
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | UTHR | 0 | $0 | 63,208 | $10,294,873 | 130,136 | $7,178,310 |
Yearly summary of insider trading at Verona Pharma Plc (VRNA) by Zaccardelli David
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | VRNA | 0 | $0 | 1,686,280 | $17,163,620 | 914,720 | $0 |
| 2024 | VRNA | 0 | $0 | 2,797,600 | $12,044,330 | 0 | $0 |
| 2023 | VRNA | 0 | $0 | 1,344,000 | $3,449,260 | 0 | $0 |
| 2022 | VRNA | 0 | $0 | 717,864 | $1,127,144 | 0 | $0 |
| 2021 | VRNA | 0 | $0 | 147,504 | $122,163 | 0 | $0 |
Yearly summary of insider trading at Melinta Therapeutics, Inc. /new/ (MLNT) by Zaccardelli David
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | MLNT | 40,000 | $200,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Dova Pharmaceuticals Inc. (DOVA) by Zaccardelli David
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | DOVA | 0 | $0 | 15,725 | $314,110 | 0 | $0 |
| 2018 | DOVA | 10,000 | $60,700 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Zaccardelli David:
1. United Therapeutics Corp (UTHR)
2. Verona Pharma Plc (VRNA)
3. Melinta Therapeutics, Inc. /new/ (MLNT)
4. Dova Pharmaceuticals Inc. (DOVA)
Table 1. Insider trading of United Therapeutics Corp (UTHR) by Zaccardelli David
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-12-29 | UTHR | Option Ex | 2,000 | 65.80 | 131,600 |
| 2015-12-22 | UTHR | Option Ex | 2,000 | 65.80 | 131,600 |
| 2015-12-15 | UTHR | Option Ex | 2,000 | 65.80 | 131,600 |
| 2015-12-08 | UTHR | Option Ex | 2,000 | 65.80 | 131,600 |
| 2015-12-01 | UTHR | Option Ex | 2,000 | 65.80 | 131,600 |
| 2015-11-24 | UTHR | Option Ex | 2,000 | 63.43 | 126,860 |
| 2015-11-17 | UTHR | Option Ex | 1,000 | 61.06 | 61,060 |
| 2015-11-10 | UTHR | Option Ex | 2,000 | 61.06 | 122,120 |
| 2015-11-03 | UTHR | Option Ex | 2,000 | 61.06 | 122,120 |
| 2015-10-27 | UTHR | Option Ex | 3,000 | 61.06 | 183,180 |
| 2015-10-06 | UTHR | Option Ex | 1,000 | 61.06 | 61,060 |
| 2015-09-29 | UTHR | Option Ex | 1,000 | 61.06 | 61,060 |
| 2015-09-22 | UTHR | Option Ex | 1,000 | 61.06 | 61,060 |
| 2015-09-15 | UTHR | Option Ex | 2,000 | 61.06 | 122,120 |
| 2015-09-08 | UTHR | Option Ex | 2,000 | 61.06 | 122,120 |
| 2015-09-01 | UTHR | Option Ex | 1,000 | 61.06 | 61,060 |
| 2015-08-25 | UTHR | Option Ex | 2,000 | 61.06 | 122,120 |
| 2015-08-18 | UTHR | Option Ex | 2,000 | 61.06 | 122,120 |
| 2015-08-11 | UTHR | Option Ex | 2,000 | 61.06 | 122,120 |
| 2015-07-21 | UTHR | Option Ex | 928 | 57.15 | 53,035 |
| 2015-07-14 | UTHR | Option Ex | 4,000 | 57.15 | 228,600 |
| 2015-07-07 | UTHR | Option Ex | 2,000 | 57.15 | 114,300 |
| 2015-06-30 | UTHR | Option Ex | 2,000 | 57.15 | 114,300 |
| 2015-06-23 | UTHR | Option Ex | 4,000 | 57.15 | 228,600 |
| 2015-06-16 | UTHR | Option Ex | 4,000 | 57.15 | 228,600 |
| 2015-06-09 | UTHR | Option Ex | 4,000 | 57.15 | 228,600 |
| 2015-06-02 | UTHR | Option Ex | 4,000 | 57.15 | 228,600 |
| 2015-05-26 | UTHR | Option Ex | 4,000 | 57.15 | 228,600 |
| 2015-05-19 | UTHR | Option Ex | 4,000 | 57.15 | 228,600 |
| 2015-04-14 | UTHR | Sale | 3,250 | 185.82 | 603,915 |
| 2015-04-14 | UTHR | Option Ex | 3,250 | 51.37 | 166,952 |
| 2015-04-09 | UTHR | Option Ex | 4,000 | 51.37 | 205,480 |
| 2015-04-09 | UTHR | Sale | 4,000 | 184.84 | 739,360 |
| 2015-04-07 | UTHR | Sale | 4,000 | 179.34 | 717,360 |
| 2015-04-07 | UTHR | Option Ex | 4,000 | 51.37 | 205,480 |
| 2015-04-02 | UTHR | Sale | 4,000 | 174.73 | 698,920 |
| 2015-04-02 | UTHR | Option Ex | 4,000 | 51.37 | 205,480 |
| 2015-03-31 | UTHR | Option Ex | 4,000 | 51.37 | 205,480 |
| 2015-03-31 | UTHR | Sale | 4,000 | 172.44 | 689,740 |
| 2015-03-26 | UTHR | Option Ex | 4,000 | 51.37 | 205,480 |
| 2015-03-26 | UTHR | Sale | 4,000 | 167.52 | 670,080 |
| 2015-03-19 | UTHR | Sale | 4,000 | 175.82 | 703,280 |
| 2015-03-19 | UTHR | Option Ex | 4,000 | 47.50 | 190,000 |
| 2015-03-24 | UTHR | Option Ex | 4,500 | 49.44 | 222,457 |
| 2015-03-24 | UTHR | Sale | 4,500 | 179.51 | 807,795 |
| 2015-03-17 | UTHR | Option Ex | 4,000 | 47.50 | 190,000 |
| 2015-03-17 | UTHR | Sale | 4,000 | 177.34 | 709,360 |
| 2015-02-24 | UTHR | Option Ex | 1,458 | 50.09 | 73,031 |
| 2015-02-24 | UTHR | Sale | 1,458 | 155.16 | 226,223 |
| 2015-02-17 | UTHR | Sale | 4,000 | 155.14 | 620,560 |
| 2015-02-17 | UTHR | Option Ex | 4,000 | 50.09 | 200,360 |
| 2015-02-10 | UTHR | Option Ex | 4,000 | 50.09 | 200,360 |
| 2015-02-10 | UTHR | Sale | 4,000 | 146.68 | 586,720 |
| 2015-02-03 | UTHR | Sale | 4,000 | 141.99 | 567,960 |
| 2015-02-03 | UTHR | Option Ex | 4,000 | 50.09 | 200,360 |
| 2015-01-27 | UTHR | Sale | 4,000 | 147.19 | 588,760 |
| 2015-01-27 | UTHR | Option Ex | 4,000 | 50.09 | 200,360 |
| 2015-01-20 | UTHR | Option Ex | 4,000 | 50.09 | 200,360 |
| 2015-01-20 | UTHR | Sale | 4,000 | 146.48 | 585,920 |
| 2015-01-13 | UTHR | Option Ex | 3,000 | 50.09 | 150,270 |
| 2015-01-13 | UTHR | Sale | 3,000 | 134.71 | 404,130 |
| 2015-01-06 | UTHR | Option Ex | 3,000 | 48.80 | 146,385 |
| 2015-01-06 | UTHR | Sale | 3,000 | 124.93 | 374,790 |
Table 2. Insider trading of Verona Pharma Plc (VRNA) by Zaccardelli David
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-08-01 | VRNA | Sale | 208,912 | 13.14 | 2,745,939 |
| 2025-08-01 | VRNA | Option Ex | 255,696 | .00 | 0 |
| 2025-07-07 | VRNA | Option Ex | 229,512 | .00 | 0 |
| 2025-06-11 | VRNA | Sale | 400,000 | 11.40 | 4,560,400 |
| 2025-05-29 | VRNA | Sale | 208,696 | 9.33 | 1,947,551 |
| 2025-05-28 | VRNA | Sale | 157,704 | 9.30 | 1,466,804 |
| 2025-05-27 | VRNA | Sale | 33,600 | 9.53 | 320,174 |
| 2025-05-02 | VRNA | Sale | 400,000 | 9.09 | 3,637,599 |
| 2025-05-01 | VRNA | Sale | 187,008 | 8.95 | 1,673,721 |
| 2025-05-01 | VRNA | Option Ex | 200,000 | .00 | 0 |
| 2025-04-29 | VRNA | Sale | 90,360 | 8.98 | 811,432 |
| 2025-04-29 | VRNA | Option Ex | 229,512 | .00 | 0 |
| 2024-12-06 | VRNA | Sale | 162,800 | 5.01 | 815,465 |
| 2024-12-04 | VRNA | Sale | 67,608 | 5.00 | 338,175 |
| 2024-12-05 | VRNA | Sale | 640,264 | 5.01 | 3,205,161 |
| 2024-12-02 | VRNA | Sale | 3,200 | 5.00 | 16,000 |
| 2024-11-29 | VRNA | Sale | 98,888 | 5.01 | 495,033 |
| 2024-11-27 | VRNA | Sale | 23,240 | 5.00 | 116,200 |
| 2024-11-25 | VRNA | Sale | 1,600 | 5.00 | 8,000 |
| 2024-11-01 | VRNA | Sale | 46,888 | 4.38 | 205,181 |
| 2024-11-04 | VRNA | Sale | 94,144 | 4.39 | 413,480 |
| 2024-10-25 | VRNA | Sale | 4,800 | 4.38 | 21,004 |
| 2024-10-24 | VRNA | Sale | 140,000 | 4.38 | 612,780 |
| 2024-10-23 | VRNA | Sale | 16 | 4.38 | 70 |
| 2024-10-18 | VRNA | Sale | 245,784 | 4.38 | 1,076,779 |
| 2024-10-21 | VRNA | Sale | 110,456 | 4.38 | 483,797 |
| 2024-10-22 | VRNA | Sale | 157,912 | 4.39 | 692,759 |
| 2024-09-11 | VRNA | Sale | 600,000 | 3.76 | 2,254,200 |
| 2024-08-12 | VRNA | Sale | 1,600 | 3.13 | 5,008 |
| 2024-08-13 | VRNA | Sale | 398,400 | 3.23 | 1,285,238 |
| 2023-08-07 | VRNA | Sale | 8,616 | 2.47 | 21,264 |
| 2023-08-04 | VRNA | Sale | 150,000 | 2.50 | 374,850 |
| 2023-08-03 | VRNA | Sale | 117,272 | 2.54 | 297,753 |
| 2023-08-01 | VRNA | Sale | 105,944 | 2.68 | 283,823 |
| 2023-08-02 | VRNA | Sale | 73,704 | 2.59 | 191,114 |
| 2023-05-01 | VRNA | Sale | 455,536 | 2.58 | 1,173,460 |
| 2023-02-01 | VRNA | Sale | 432,928 | 2.56 | 1,106,996 |
| 2022-08-09 | VRNA | Sale | 600,000 | 1.75 | 1,050,000 |
| 2022-08-01 | VRNA | Sale | 32,904 | .70 | 23,032 |
| 2022-05-03 | VRNA | Sale | 32,904 | .50 | 16,320 |
| 2022-02-03 | VRNA | Sale | 52,056 | .73 | 37,792 |
| 2021-11-02 | VRNA | Sale | 52,056 | .64 | 33,367 |
| 2021-08-03 | VRNA | Sale | 17,656 | .75 | 13,277 |
| 2021-08-03 | VRNA | Sale | 16,000 | .76 | 12,208 |
| 2021-08-04 | VRNA | Sale | 18,400 | .74 | 13,671 |
| 2021-03-01 | VRNA | Sale | 43,392 | 1.14 | 49,640 |
Table 3. Insider trading of Melinta Therapeutics, Inc. /new/ (MLNT) by Zaccardelli David
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-05-29 | MLNT | Buy | 40,000 | 5.00 | 200,000 |
Table 4. Insider trading of Dova Pharmaceuticals Inc. (DOVA) by Zaccardelli David
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-10-01 | DOVA | Sale | 5,275 | 27.90 | 147,172 |
| 2019-07-02 | DOVA | Sale | 10,450 | 15.97 | 166,938 |
| 2018-12-20 | DOVA | Buy | 10,000 | 6.07 | 60,700 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Zaccardelli David
(President and CEO of Verona Pharma Plc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.